| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,339,000 | 4,141,000 | 4,722,000 | 4,493,000 | | Cost of Revenue | 1,200,000 | 8,000 | 2,832,000 | (1,991,000) | | | Gross Profit | 3,139,000 | 4,133,000 | 1,890,000 | 6,484,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,251,000 | 2,677,000 | 200,000 | 4,747,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 485,000 | 439,000 | 436,000 | 404,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,403,000 | 1,017,000 | 1,254,000 | 1,333,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 148,000 | 257,000 | (38,000) | (151,000) | | Earnings Before Interest And Taxes | 1,544,000 | 1,268,000 | 1,208,000 | 1,175,000 | | Interest Expense | 188,000 | 180,000 | 187,000 | 194,000 | | Income Before Tax | 1,356,000 | 1,088,000 | 1,021,000 | 981,000 | | Income Tax Expense | 599,000 | 430,000 | 310,000 | 295,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 757,000 | 658,000 | 711,000 | 686,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (1,000) | 1,000 | 21,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 757,000 | 657,000 | 712,000 | 707,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $757,000 | $657,000 | $712,000 | $707,000 |
|
1.52% Nasdaq 0.00%
Income Statement
